Get research updatesPublic study records, presented in a clearer and more patient-friendly format for mental health research discovery.
A Study of the Effects of Oxytocin in Adults With Binge-eating Disorder
Read the official source — NCT05664516A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effects of Intranasal Oxytocin in Adults With Binge-eating Disorder
This study evaluates the safety of Aticaprant for people with schizophrenia.
A Study of the Intestinal Microbiota in Children and Adolescents With Eating Disorders. A Perspective From Psychoneuroimmunology
Read the official source — NCT07066033Getting Into the Guts of Eating Disorders in Children and Adolescents. A Perspective From Psychoneuroimmunology.
Study of Tirzepatide’s Role in Affective and Neurobiological Dynamics (STRAND) Among Adults with Binge Eating Disorder (BED)
Using Vagal Nerve Stimulation In Conjunction With NRT For Smoking Cessation
A Randomized, Double-blind, Placebo-Controlled Phase 3 Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Once-Daily Oral Administration of Vortioxetine in Japanese Pediatric Patients 12 to 17 Years of Age With Major Depressive Disorder (MDD)
A Study to Assess Adverse Events and Change in Disease Activity of Oral Icalcaprant in Adult Participants With Bipolar I or II Disorder
Read the official source — NCT06696755Researchers compare two doses of icalcaprant with placebo to find out whether the medicine improves depression symptoms in adults with bipolarity type I or II. Participants take capsules for six weeks while researchers also monitor side effects.
A Study to Assess Adverse Events, Change in Disease Activity, and How Oral Emraclidine Moves Through the Body in Adult Participants With Schizophrenia
Read the official source — NCT07145918This study evaluates the safety and effectiveness of Emraclidine for people with schizophrenia.
A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder.
Read the official source — NCT04777357Researchers are comparing Cariprazine and placebo, tracking side effects to assess safety in children with bipolarity type I.
Researchers are comparing Icalcaprant and placebo to find out how the approaches affect depression symptoms in people with depression.
We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.